🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/01/2008 8,70 8,76 8,40 8,52 -4,05% 4,14% 87.983
03/01/2008 8,70 8,88 8,16 8,88 +4,23% 8,28% 96.817
02/01/2008 8,52 8,64 8,34 8,52 +0,71% 3,52% 132.100
31/12/2007 8,10 8,46 8,04 8,46 +7,63% 5,19% 165.283
28/12/2007 7,98 8,40 7,80 7,86 -2,96% 7,52% 146.133
27/12/2007 8,10 8,52 8,10 8,10 -1,46% 5,19% 118.933
26/12/2007 8,22 8,40 7,98 8,22 -2,14% 5,11% 190.233
24/12/2007 8,58 8,58 8,22 8,40 -1,41% 4,20% 82.650
21/12/2007 8,16 8,52 8,16 8,52 +2,90% 4,41% 140.700
20/12/2007 8,34 8,70 8,22 8,28 +1,47% 5,76% 107.250
19/12/2007 8,70 8,70 8,16 8,16 -2,86% 6,21% 101.033
18/12/2007 8,52 8,82 8,28 8,40 -0,71% 6,34% 100.900
17/12/2007 9,84 9,84 8,34 8,46 -12,96% 15,24% 154.250
14/12/2007 10,08 10,32 9,72 9,72 -3,57% 5,95% 111.833
13/12/2007 10,20 10,68 9,60 10,08 -24,66% 10,59% 550.450
12/12/2007 13,68 13,80 13,20 13,38 -0,45% 4,39% 32.667
11/12/2007 13,80 14,04 13,38 13,44 -3,03% 4,78% 33.350
10/12/2007 13,68 14,10 13,68 13,86 +1,32% 3,07% 28.033
07/12/2007 13,86 14,28 13,38 13,68 -2,56% 6,49% 45.933
06/12/2007 14,22 14,22 13,62 14,04 +0,00% 4,22% 29.367
05/12/2007 14,22 14,22 13,92 14,04 +0,86% 2,11% 28.517
04/12/2007 14,46 14,64 13,86 13,92 -3,73% 5,39% 39.567
03/12/2007 14,46 15,00 14,10 14,46 +3,43% 6,22% 78.567
30/11/2007 14,34 14,34 13,62 13,98 -2,51% 5,02% 31.750
29/11/2007 14,10 14,52 13,80 14,34 +0,84% 5,11% 38.000
28/11/2007 13,98 14,34 13,14 14,22 +1,72% 8,58% 58.933
27/11/2007 14,34 14,70 13,86 13,98 -3,32% 5,86% 38.050
26/11/2007 15,00 15,06 13,74 14,46 -3,21% 8,80% 36.883
23/11/2007 14,52 14,94 14,34 14,94 +4,62% 4,13% 16.500
21/11/2007 14,64 14,94 14,10 14,28 -4,80% 5,74% 39.383